From: Splanchnic venous thrombosis in a nephrotic patient following COVID-19 infection: a case report
1. Abdominal pain in COVID-19 patients could be a harbinger of serious pathology such as intestinal ischemia and warrants careful assessment | |
2. Patients with a priori VTE risk factors are at a higher risk for thrombotic events when infected with SARS-CoV-2, even as outpatients | |
3. Prothrombotic risk is dynamic requiring vigilance on the part of the health care team | |
4. Past history of VTE, even if provoked, is a major risk factor for recurrence | |
5. A relapse of the nephrotic syndrome should dictate immediate assessment of VTE risk and consideration of urgent anticoagulation in high-risk individuals |